CLASS II Device recall · Reported 24 Jul 2019 · FDA Enforcement Report

Alpha Conducting solution product codes: 3310-25 ASCR recalled

Pharmaceutical Innovations is recalling Alpha Conducting solution product codes: 3310-25 ASCR, distributed nationwide in the US. The recall was initiated on 19 Jun 2019 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot # 032014-25, 060515-25,101615-25, 011716-25, 021317-25, 080117-25, 010118A-25, 041618-25, 071618-25, 102018A-25
Quantity recalledN/A

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1972-2019
FDA event ID
83213
Recalling firm
Pharmaceutical Innovations, Newark, NJ
Classification
Class II
Status
Terminated
Recall initiated
19 Jun 2019
FDA classified
12 Jul 2019
Reported
24 Jul 2019
Type
Voluntary: Firm initiated
Customers notified by
E-Mail
Reason category
Potency & Assay

Timeline

19 Jun 2019Recall initiated by company
12 Jul 2019Classified by FDA+23 days
24 Jul 2019Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Potential for failed stability antimicrobial effectiveness testing.

Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.

Product as listed by the FDA

Alpha Conducting solution product codes: 3310-25 ASCR - Product Usage: Electrode Conductivity Spray Solution.

Where it was distributed

US nationwide distribution including the states of AZ, CA, CT, FL, IL, MA, MI, MN, NC, NJ, NY, OH, PA, RI, TX, TN, VT, WV. Distributed Internationally to accounts in Australia, France, Germany, Hong Kong, Saudi Arabia and Canada.

Nationwide ArizonaCaliforniaConnecticutFloridaIllinoisMassachusettsMichiganMinnesotaNorth CarolinaNew JerseyNew YorkOhioPennsylvaniaRhode IslandTennesseeTexasVermontWest Virginia

Questions about this recall

Is Alpha Conducting solution product codes: 3310-25 ASCR recalled?

Yes. Pharmaceutical Innovations recalled Alpha Conducting solution product codes: 3310-25 ASCR on 19 Jun 2019. The recall is Class II and its status is Terminated. Recall number Z-1972-2019.

Why was it recalled?

Potential for failed stability antimicrobial effectiveness testing.

Which lots are affected?

Lot # 032014-25, 060515-25,101615-25, 011716-25, 021317-25, 080117-25, 010118A-25, 041618-25, 071618-25, 102018A-25

Where was it sold?

US nationwide distribution including the states of AZ, CA, CT, FL, IL, MA, MI, MN, NC, NJ, NY, OH, PA, RI, TX, TN, VT, WV. Distributed Internationally to accounts in Australia, France, Germany, Hong Kong, Saudi Arabia and Canada.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Pharmaceutical Innovations

All 6

Other Other Medical Devices recalls

All 13,778